Allergan Return on Investment 2006-2018 | AGN

Current and historical return on investment (ROI) values for Allergan (AGN) over the last 10 years.
Allergan ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-09-30 $-0.95B $92.75B -0.99%
2018-06-30 $-5.23B $95.27B -5.35%
2018-03-31 $-5.67B $98.28B -5.71%
2017-12-31 $-5.92B $99.68B -5.91%
2017-09-30 $-6.73B $97.71B -6.61%
2017-06-30 $-2.97B $101.68B -2.77%
2017-03-31 $-2.56B $101.42B -2.32%
2016-12-31 $-1.83B $106.17B -1.60%
2016-09-30 $-1.53B $120.91B -1.31%
2016-06-30 $-2.64B $113.72B -2.27%
2016-03-31 $-2.63B $116.00B -2.26%
2015-12-31 $-3.13B $116.72B -2.71%
2015-09-30 $-3.16B $118.13B -3.25%
2015-06-30 $-3.07B $113.39B -3.89%
2015-03-31 $-2.38B $114.11B -4.30%
2014-12-31 $-1.50B $43.17B -4.76%
2014-09-30 $-0.94B $44.24B -3.71%
2014-06-30 $0.50B $20.43B 3.01%
2014-03-31 $-0.17B $18.08B -1.24%
2013-12-31 $-0.42B $18.06B -3.59%
2013-09-30 $-0.34B $9.43B -3.49%
2013-06-30 $-0.40B $9.72B -4.68%
2013-03-31 $0.16B $9.87B 2.13%
2012-12-31 $0.32B $10.11B 5.20%
2012-09-30 $0.46B $4.71B 9.80%
2012-06-30 $0.51B $4.66B 10.94%
2012-03-31 $0.53B $4.82B 11.52%
2011-12-31 $0.52B $4.41B 11.66%
2011-09-30 $0.42B $4.64B 9.51%
2011-06-30 $0.32B $4.50B 7.24%
2011-03-31 $0.32B $4.39B 7.28%
2010-12-31 $0.31B $4.30B 7.08%
2010-09-30 $0.35B $4.38B 8.19%
2010-06-30 $0.43B $4.29B 10.66%
2010-03-31 $0.40B $4.25B 11.39%
2009-12-31 $0.38B $4.17B 12.51%
2009-09-30 $0.37B $3.31B 13.55%
2009-06-30 $0.35B $2.38B 13.20%
2009-03-31 $0.36B $2.41B 13.00%
2008-12-31 $0.36B $2.93B 12.64%
2008-09-30 $0.33B $2.88B 11.99%
2008-06-30 $0.31B $2.80B 11.18%
2008-03-31 $0.28B $2.73B 10.04%
2007-12-31 $0.26B $2.75B 9.26%
2007-09-30 $-0.29B $2.78B -10.29%
2007-06-30 $-0.30B $2.74B -10.80%
2007-03-31 $-0.40B $2.79B -14.31%
2006-12-31 $-0.42B $2.81B -15.39%
2006-09-30 $0.08B $2.74B 3.10%
2006-06-30 $0.10B $2.71B 3.64%
2006-03-31 $0.19B $2.71B 7.10%
2005-12-31 $0.22B $2.69B 7.99%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $51.409B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.738B 6.05
Mylan (MYL) United Kingdom $15.753B 6.49
Bausch Health Cos (BHC) Canada $8.275B 5.99
Dr Reddy's Laboratories (RDY) India $6.267B 24.99
Supernus Pharmaceuticals (SUPN) United States $1.909B 18.08
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.730B 2.88
Amphastar Pharmaceuticals (AMPH) United States $1.014B 109.95
Homology Medicines (FIXX) United States $0.937B 0.00
Assembly Biosciences (ASMB) United States $0.634B 0.00
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.511B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.386B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.273B 0.00
Sol-Gel Technologies (SLGL) Israel $0.118B 0.00
Teligent (TLGT) United States $0.086B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.085B 0.00
Aevi Genomic Medicine (GNMX) United States $0.077B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Acasti Pharma (ACST) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Agile Therapeutics (AGRX) United States $0.028B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.005B 0.00